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1 Yohei Miyamoto and Yasunori Iwao contributed eqThe effect of the uremic solute indoxyl sulfate (IS) on scavenging superoxide anion radicals (O2 )
generated from both the xanthine/xanthine oxidase (X/XO) system and activated neutrophils was
investigated by electron paramagnetic resonance spectroscopy, combined with 2-ethoxycarbonyl-
2-methyl-3,4-dihydro-2H-pyrrole-1-oxide (EMPO). The ﬁndings show that the presence of normal-
physiological serum concentrations of IS (0.1–10 lM) resulted in decreased formation of EMPO-
superoxide adduct without affecting XO activity. Furthermore, IS showed scavenging activity against
cell-derived O2 generated from activated neutrophils. In addition, IS also eliminated hydroxyl rad-
icals. These ﬁndings suggest that IS acts as a novel endogenous antioxidant under normal-physiolog-
ical conditions.
 2010 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction ylguanidine); (3) an increase in hormone production (parathyroidWhen kidney function is impaired, a variety of pathological
changes occur that are collectively referred to as uremic syndrome.
A part of this syndrome involves elevated serum levels of a number
of substances [1]. In patients with chronic kidney diseases (CKD),
uremic toxins accumulate in the serum by a combination of the fol-
lowing four mechanisms: (1) a decrease in renal clearance (indoxyl
sulfate (IS)); (2) the accumulation of abnormal metabolites (meth-on behalf of the Federation of Euro
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ually to this work.hormone); and (4) a decreased rate of catabolism by the kidney
(b2-microgloblin) [2].
IS, an extensively investigated uremic toxin, is derived from die-
tary protein including tryptophan and contains an indole ring. It is
present at high levels in the serum of patients with CKD (the serum
concentration of CKD patients is 100 lM–1mM versus 0.1–10 lM
in healthy subjects). Recent ﬁndings indicate that IS is likely in-
volved in both the progression of CKD and the development of
complications. In fact, we and other researchers have recently re-
ported that IS causes tubulointerstitial injuries in rodent models
[3,4] and produces oxidative stress in various cell systems, such
as renal proximal tubular cells, mesangial cells and endothelial
cells [5–8]. Moreover, excessive dietary supplementation of trypto-
phan, a precursor of IS, enhanced plasma lipid peroxidation in rats
[9]. These observations suggest that IS has an adverse effect via the
enhancement of oxidative stress in vivo.
On the other hand, from a structural perspective, it is possible
that endogenous indole derivatives have the potential to function
as an antioxidant against various reactive oxygen species (ROS),
attributed to the electron-attracting nitrogen atom (–NH) in the
pyrrole ring [10]. For example, melatonin (MLT) precursorpean Biochemical Societies.
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(OH) and superoxide anion radicals (O2 ) [11,12]. In addition, MLT,
serotonin and the MLT metabolite 6-OH-MLT also showed antiox-
idant activity against various free radicals [13,14]. Interestingly,
Chyan et al. reported that indole-3-propionic acid scavenges OH
and also showed potent neuroprotective properties against the
Alzheimer b-amyloid [15]. Based on these reports, we hypothesize
that, although under high serum levels, IS functions as a prooxi-
dant due to an enhancement in oxidative stress, it may also func-
tion as an antioxidant under normal-physiological conditions.
However, the detailed information on the role of IS under nor-
mal-physiological conditions does not appear to be available.
In the current study, using a luminol-dependent chemilumines-
cence assay and electron paramagnetic resonance (EPR) spectros-
copy, combined with a 2-ethoxycarbonyl-2-methyl-3,4-dihydro-
2H-pyrrole-1-oxide (EMPO)-spin trapping technique, we examined
the issue of whether normal-physiological concentrations of IS
(0.1–10 lM) show scavenging activity for O2 , generated by both
the xanthine/xanthine oxidase (X/XO) system and neutrophils trea-
ted with LPS. The ﬁndings were compared with the data for other
antioxidant compounds, such as Cu, Zn-superoxide dismutase (Cu,
Zn-SOD, an O2 scavenger) and allopurinol (ALP) (a XO inhibitor),
and were also compared with that for other uremic toxins under
normal non-uremic concentrations [16]. In addition, the effect of
IS on OH generated by a H2O2/UV system was also investigated.2. Materials and methods
2.1. Chemicals and materials
X, XO, IS, uric acid sodium salt, Cu, Zn-SOD and ALP were
purchased from Sigma Chemical Co. (St. Louis, MO, USA). Diethyl-
ene-triamine-pentaacetic acid (DTPA) was purchased from Dojindo
Laboratories (Kumamoto, Japan). EMPO and 5,5-dimethyl-1-pyrro-
line N-oxide (DMPO) were purchased from Alexis Biochemicals
(Lausen, Switzerland). Luminol, indolacetate (IA), hippurate (HA)
and p-cresol were purchased from Nakalai Tesque Inc. (Kyoto, Ja-
pan). 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF)
was synthesized as described previously (Tsutsumi et al., 1999).
All other reagents used were of the highest grade available from
commercial sources.
2.2. EPR spectroscopy in combination with EMPO and DMPO spins
trapping technique
O2 was assayed by EPR spin trapping with EMPO and the scav-
enging activity was calculated from the relative intensity of the
peak corresponding to the EMPO-superoxide adduct (EMPO-OOH)
EPR signal. The reaction mixtures contained 100 lg/ml X, 0.02 U/
ml XO, 100 lM DTPA and 20 mM EMPO in the absence or presence
of varying concentrations of IS andwere immediately transferred to
quartz EPR ﬂat cells. EPR spectra were recorded at room tempera-
ture on a JES-TE 200 EPR spectrometer (JEOL, Tokyo, Japan) under
the following conditions: modulation frequency, 100 kHz; modula-
tion amplitude, 50 Gauss; scanning ﬁeld, 335.2 ± 5 mT; receiver
gain, 300–500; response time, 0.03 s; sweep time, 2 min; micro-
wave power, 40 mW; and microwave frequency, 9.43 GHz. In order
to conﬁrm the speciﬁcity of the reaction, 100 lg/ml ALP and 5 U/ml
Cu, Zn-SOD were added to the above mixture.
OH was assayed by EPR spin trapping with DMPO and the scav-
enging activity was calculated from the relative intensity of the
peak for the DMPO-hydroxyl radical adduct (DMPO-OH) EPR sig-
nal. The reaction mixtures contained 100 lM DTPA, 9 mM DMPO
and 500 lM H2O2 in the absence or presence of varying concentra-
tions of IS and were immediately transferred to the EPR ﬂat celland irradiated with UV (254 nm) for 1 min. EPR spectra were ob-
tained immediately after the UV-irradiation. This analysis was
done under the same conditions as were used for the previous
EPR experiments. After recording the EPR spectra, the signal inten-
sities of the DMPO-OH or the EMPO-OOH adducts were normalized
against that of a manganese oxide (Mn2+) signal, in which Mn2+
served as an internal control.
2.3. Chemiluminescence assay using activated neutrophils
The scavenging activity of IS against O2 from the neutrophils
was determined using a MiniLumat LB 9506 luminometer
(Berthold Technologies, Bad Wildbad, Germany). The neutrophils
(1.0  107 cells/ml) were pre-treated with LPS (1 lg/ml) for
30 min at 37 C to activate the cells and generate O2 . Aliquots of
this cell suspension were combined with 100 lM DTPA and
500 lM luminol in HBSS in the absence or presence of varying
concentrations of IS and 1 U/ml Cu, Zn-SOD. Chemiluminescence
was obtained from a graph of the slope of the counts versus time.
Isolation of polymorphonuclear neutrophils are given in Supple-
mentary data.
2.4. Chemiluminescence assay using X/XO system
The chemiluminescence response, induced by O2 generated by
an X/XO system, was measured by using a MiniLumat LB 9506
luminometer. The reaction was initiated by adding 40 lg/ml X to
a sodium phosphate buffer (pH 7.4) containing 0.004 U/ml XO,
250 lM DTPA and 500 lM luminol in the absence or presence of
each physiological concentration of IA, HA, CMPF, uric acids, and
p-cresol (Fig. 3). In order to conﬁrm the speciﬁcity of the reaction,
a solution containing 40 lg/ml ALP and 5 U/ml Cu, Zn-SOD were
added to the above mixture. The Chemiluminescence response
was continuously recorded for 10 min at room temperature.
2.5. Statistics analyses
Statistical analyses were performed using the Student’s t-test. A
probability value of P < 0.05 was considered to be statistically
signiﬁcant.3. Results
3.1. IS scavenges O2 generated by X/XO system
Fig. 1A shows data for the radical scavenging activity of IS
examined by EPR using an EMPO spin trapping technique. EMPO
was generally considered to be a good candidate for quantifying
and trapping O2 and has been extensively used as an efﬁcient spin
trapping agent for applications in vitro and in vivo [17,18]. In these
experiments, Cu, Zn-SOD (O2 scavenger) and ALP (XO inhibitor)
were used as positive controls. These EPR signals generated by
the X/XO system were completely inhibited by the action of both
Cu, Zn-SOD and ALP. In the presence of 10 lM IS, the EPR signals
were also signiﬁcantly decreased. When the production of O2
was calculated using the EPR spectra (Fig. 1B), the concentration
of O2 was found to be about 2.1 lM in the control and IS markedly
inhibited O2 production. These results demonstrate that normal-
physiological concentration of IS, exhibited radical scavenging
activity against O2 .
3.2. IS does not affect XO activity
Generally, XO uses X/hypoxanthine and oxygen as substrates to
generate uric acid and O2 . Although decreases in the EPR signal
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Fig. 1. Indoxyl sulfate scavenges superoxide anion radicals generated by a
xanthine/xanthine oxidase system. (A) The EPR spectrum of EMPO spin adducts
of O2 generated in the xanthine/xanthine oxidase system; (B) the quantitation of
the O2 concentration. Values are expressed as the mean ± S.D. (n = 3–4).
*P < 0.05,
**P < 0.01 in comparison to the control.
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Fig. 2. The antioxidant properties of IS to LPS-stimulated neutrophils, as assessed
by luminol chemiluminescence. Values are expressed as the mean ± S.D. (n = 3).
*P < 0.05, **P < 0.01 in comparison to the control.
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sary to examine whether this phenomenon was due to the inhibi-
tory action of IS on XO or to direct O2 scavenging activity. The
formation of uric acid and 2-amino-4,7-dihydroxypteridine
(isoxanthopterin), adducts catalyzed by XO from X and 2-amino-
4-hydroxypteridine (pterin), and oxygen consumption were not
affected by the IS treatment. Further details are given in
Supplementary data. Based on these results, since the normal-
physiological serum levels of IS had no effect on XO activity, it
can be concluded that IS directly scavenges O2 generated by the
X/XO system.
3.3. IS scavenges O2 generated by activated neutrophils
We also examine whether IS shows scavenging activity against
O2 in a cell system. O

2 was also generated from LPS-stimulated
neutrophils by means of luminol-dependent chemiluminescence,
because white corpuscle cells such as monocytes and neutrophils
are major sources of various free radicals within blood vessels.
As shown in Fig. 2, IS at concentrations of 0.1–10 lM also signiﬁ-
cantly decreased the chemiluminescence. It is especially notewor-thy that the quenching effect of IS at 10 lMwas comparable to that
of Cu, Zn-SOD. These data suggest that IS also functions as a poten-
tial antioxidative compound against cell-derived O2 .
3.4. IS has strong O2 - scavenging activity compared with other uremic
toxins
As shown in above, within the concentrations observed under
normal-physiological conditions, IS would be a potent endogenous
scavenger of O2 . Thus, we investigate whether other uremic toxins
also exhibit antioxidative activity within the concentration range
for non-CKD conditions. IA, HA, CMPF, uric acids, and p-cresol,
were used, as representative toxins (Fig. 3A) and their scavenging
activities against O2 under normal-physiological concentrations,
respectively were evaluated using the luminol chemiluminescence
system. As shown in Fig. 3B, signiﬁcant decreases in chemilumi-
nescence were observed in the cases of IS, uric acids, and p-cresol,
whereas IA and HA showed no effects. Recent evidences demon-
strated that in human, p-cresol was mainly circulated in the form
of its sulfated conjugate, p-cresyl sulfate, and it increased leuko-
cyte oxidative burst activity [19,20]. Thus, it is interesting to know
whether p-cresyl sulfate also possesses radical scavenging activity
as well as p-cresol. However, from a structural perspective, it is
possible to deduce that the antioxidative potential of p-cresyl sul-
fate may be weaker than that of p-cresol because conjugate looses
the phenolic OH which is generally corresponded to the radical
scavenging property of phenolic compounds [21]. If this is correct,
the radical scavenging activity of p-cresyl sulfate against O2 may
be weaker than that of IS since this activity was comparable to
p-cresol (Fig. 3B). Of course, further studies using p-cresyl sulfate
would be required to provide precise information regarding the
roles of p-cresol as a radical scavenger. Collectively, these results
and the data shown in Fig. 1, indicate that IS is an effective scaven-
ger of O2 , among the endogenous uremic toxins.
3.5. IS scavenges OH generated by H2O2/UV system
As mentioned in Section 1, MT, another endogenous indole
derivative, was an effective scavenger of, not only O2 , but also
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Fig. 3. Indoxyl sulfate has a strong scavenging activity compared to other uremic toxins. (A) Chemical structures of the uremic toxins used in this study; (B) the antioxidant
properties of uremic toxins assessed by luminol chemiluminescence. Values are expressed as the mean ± S.D. (n = 3). *P < 0.05, **P < 0.01 in comparison to the control.
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properties OH. In this study, OH was generated by means of an
H2O2/UV system. As shown in Fig. 4, IS at 1–10 lM concentrations
also eliminated OH signiﬁcantly, suggesting that, IS also acts as a
scavenger of OH at normal-physiological concentrations.Control
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Fig. 4. Scavenging activity of IS against OH generated by a H2O2/UV system.
Relative antioxidant activity of DMPO spin adducts of OH generated by H2O2/UV
system. Values are expressed as the mean ± S.D. (n = 3). *P < 0.05, **P < 0.01 in
comparison to the control.4. Discussion
The present study demonstrated, for the ﬁrst time, that IS, at
normal serum concentrations, exhibited radical scavenging activ-
ity, especially against O2 . It is well known that O

2 species is an
important initiator, in that it is capable of generating various reac-
tive oxygen species, such as OH and peroxynitrite, at physiological
conditions. In particular, O2 produced by the X/XO system was
known to be a signiﬁcant activator of endothelial NADPH oxidase,
one of other major sources of O2 . Such O

2 mediate pro-oxidative,
proinﬂammatory, and procoagulatory changes in primary endothe-
lial cell lines. Its damage induced by O2 can disrupt the balance be-
tween vasodilation and vasoconstriction, which affects arterial
remodeling, inﬂammatory mediators, and hemostasis and throm-
bosis. Thus, oxidative stress induced by O2 produced in vascular
cells will cause accumulative injuries to the endothelium and con-
sequently are likely involved in the pathogenesis of cardiovascular
and metabolic diseases, including atherosclerosis, ischemia–reper-
fusion injury, diabetes, and hypertension [22–24], if they are not
effectively controlled. In other words, an adequate scavenger for
O2 is necessary to prevent the damage to the endothelium induced
by O2 .
Our study clearly showed that, within the concentrations ob-
served under normal-physiological conditions, IS is a potent
endogenous scavenger of O2 generated not only from X/XO sys-
tem, but also from activated neutrophils. In addition, when the
normal-physiological concentration of IS at 1 lMwas added to hu-
man umbilical vein endothelial cells (HUVECs), a signiﬁcant de-
2820 Y. Miyamoto et al. / FEBS Letters 584 (2010) 2816–2820crease in intracellular ROS was found, even though IS at levels in
CKD conditions such as 100 or 500 lM signiﬁcantly enhanced the
intercellular ROS in HUVECs as previously reported [8]. Further de-
tails are given in Supplementary data. These observations predict
that, in addition to extracellular SOD, IS may be one of the impor-
tant endogenous compounds acting as an O2 scavenger in the
blood circulation and also serves to protect endothelial functions.
Furthermore, IS also exhibited radical elimination properties
against OH. These ﬁndings suggest that IS plays a role as a novel
endogenous antioxidant under normal-physiological conditions.
Although the differences of antioxidant activity between IS and
other indole compounds remained unclear, the sulfate might be
favorable to enhance the reactivity of the electron-attracting nitro-
gen atom (–NH) in the pyrrole ring rather than other substituents
because this nitrogen atom was likely to be responsible for the
antioxidative potential of indoles.
As mentioned in Section 1 and Supplementary data, IS at levels
in CKD conditions, signiﬁcantly produced oxidative stress in vari-
ous cell systems. At a glance, this may seem to be in conﬂict with
the present results in which IS was found to act as an antioxidant.
If this is correct, IS has both pro- and antioxidant properties,
depending on its concentration. These interesting phenomena
may imply that under non-CKD condition, antioxidative activity
of IS greatly exceeded the intracellular ROS produced by IS, while
under CKD condition, it was well over the radical scavenging
activity of IS. In fact, such complex redox alternation is not an
exception and has been also observed for other endogenous com-
pounds. For example, uric acid functions as an antioxidant at low
concentrations, while it causes ROS production at high concentra-
tions [25]. Although further in vitro and in vivo studies will be
needed to clarify the dual roles of IS with respect to its pro- or
antioxidant properties, our results also explain, at least in part,
the protective role of IS against oxidative stress under normal-
physiological conditions.
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